More forecasts: Atlanta 30 day forecast
Indy Cancer Docs Help Deliver Game-Changing Bladder Therapy
Apr 09, 2026
Indiana University physicians were co‑authors on a NEJM trial showing enfortumab vedotin plus pembrolizumab produced large survival gains for certain bladder cancer patients. IU sites helped enroll and analyze the data behind the finding.
Eric Christopher Named TechPoint President & CEO
Apr 06, 2026
Eric Christopher, the co-founder of Zylo, will take over as TechPoint’s president and CEO on April 7, stepping into a statewide role focused on talent, capital and AI. The hire follows a national search and the departure of Ting Gootee to CICP.
Lilly Shells Out $6.3 Billion For Boston Sleep-Drug Player Centessa
Mar 31, 2026
Eli Lilly will buy Boston‑based Centessa for about $6.3B, adding an orexin agonist program led by cleminorexton. The deal pays $38 per ADS up front and could reach $47 with milestones.












